| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 79 | 710 | 650 | $90 | $274.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 166 | 690 | 650 | $90 | $235.4K |
| 87502 | The lab analyst performs a test to determine the presence of multiple types or subtypes of influenza virus through nucleic acid detection using multiplex amplified probe technique and possibly… | 30 | 30 | 1,040 | $50 | $157.3K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 45 | 50 | 980 | $30 | $111.1K |
| 99442 | N/A | 43 | 60 | 80 | $130 | $67.7K |
| J0897 | Injection, denosumab, 1 mg | 2 | 10 | 80 | $490 | $50.9K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 47 | 230 | 140 | $20 | $16.1K |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 55 | 90 | 260 | $1 | $6.1K |
| 99397 | The provider performs an established well–patient visit for a patient who is 65 years or older. | 13 | 30 | 90 | $30 | $5.6K |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 32 | 180 | 120 | $10 | $4.7K |